Cardiovascular Systems Inc 4
4 · Cardiovascular Systems Inc · Filed Aug 19, 2015
Insider Transaction Report
Form 4
Martin David
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2015-08-17$24.01/sh−9,780$234,827→ 507,068 total - Sale
Common Stock
2015-08-18$23.97/sh−7,908$189,564→ 499,160 total
Holdings
- 350(indirect: By Children)
Common Stock
- 850(indirect: By Children)
Common Stock
- 234,395
Stock Option (right to buy)
Exercise: $12.15Exp: 2017-12-11→ Common Stock (234,395 underlying) - 32,350
Stock Option (right to buy)
Exercise: $8.75Exp: 2019-03-01→ Common Stock (32,350 underlying) - 90,580
Stock Option (right to buy)
Exercise: $7.90Exp: 2017-06-11→ Common Stock (90,580 underlying) - 850(indirect: By Children)
Common Stock
Footnotes (4)
- [F1]In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.93 to $24.12 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.82 to $24.09 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Fully exercisable.